...
机译:诊断免疫组织化学的最佳实践:乳腺病理中的肌上皮标志物
Rajan Dewar, MD, PhD, Oluwole Fadare, MD, Hannah Gilmore, MD, Allen M. Gown, MDAccepted for publication July 22, 2010.From the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (Drs Dewar and Gilmore), the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Fadare), and the Department of Pathology and Laboratory Medicine, University of British Columbia, Canada, and PhenoPath Laboratories, Seattle, Washington (Dr Gown).The authors have no relevant financial interest in the products or companies described in this article.This article is provided for educational purposes only and is not intended to suggest either a practice standard or the only acceptable pathway for diagnostic evaluation. The views presented reflect the authors' opinions. The application of these opinions to a particular medical situation must be guided by the informed medical judgment of the responsible pathologist(s) based on the individual circumstances presented by the patient. The College of American Pathologists has no responsibility for the content or application of the views expressed herein.Reprints: Rajan Dewar, MD, PhD, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, YA 309, Boston, MA 02215 (e-mail: rdewar@bidmc. harvard.edu).,;
机译:免疫组织化学诊断的最佳实践:乳腺病理中的肌上皮标志物。
机译:P40免疫抑制剂在乳房病理学日常实践中,不优于P63作为肌膜细胞标记
机译:肌上皮标记物的免疫组织化学改善了乳腺癌微浸润识别的一致性
机译:网络人体/机器人合作界面,用于乳房病理学的远程诊断
机译:数字病理的定量组织形态计量学作为辅助诊断:预测ER +乳腺癌的结局。
机译:免疫组化在肌上皮细胞标记物上有多种表达方式的低度腺鳞癌
机译:乳腺低级腺瘤性癌患者免疫组织化学中肌上皮细胞标志物的不同表达模式:案例研究